Alerts will be sent to your verified email
Verify Email
SYNGENE
|
Syngene Internation.
|
Piramal Pharma
|
Laurus Labs
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
14.02 % | 4.5 % | 20.05 % |
|
5yr average Equity Multiplier
|
1.65 | 1.97 | 2.06 |
|
5yr Average Asset Turnover Ratio
|
0.51 | 0.53 | 0.74 |
|
5yr Avg Net Profit Margin
|
16.68 % | 4.14 % | 12.47 % |
|
Price to Book
|
6.79 | 2.67 | 5.72 |
|
P/E
|
56.71 | 0.0 | 149.23 |
|
5yr Avg Cash Conversion Cycle
|
-1572.22 Days | -17.8 Days | 109.81 Days |
|
Inventory Days
|
17.83 Days | 68.38 Days | 110.32 Days |
|
Days Receivable
|
50.73 Days | 76.2 Days | 117.42 Days |
|
Days Payable
|
-1569.1 Days | 156.5 Days | 143.67 Days |
|
5yr Average Interest Coverage Ratio
|
16.65 | 3.08 | 9.19 |
|
5yr Avg ROCE
|
14.42 % | 6.74 % | 24.17 % |
|
5yr Avg Operating Profit Margin
|
32.85 % | 18.18 % | 24.88 % |
|
5 yr average Debt to Equity
|
0.2 | 0.63 | 0.56 |
|
5yr CAGR Net Profit
|
4.36 % | -53.67 % | -9.19 % |
|
5yr Average Return on Assets
|
8.45 % | 2.39 % | 9.61 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
54.79 % | 35.02 % | 27.19 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-15.79 % | 0.23 % | -0.26 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
8.65 % | 8.47 % | 4.63 % |
|
Syngene Internation.
|
Piramal Pharma
|
Laurus Labs
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|